Showing posts with label customs. Show all posts
Showing posts with label customs. Show all posts

Wednesday, September 30, 2009

New French Crackdown on “Counterfeit Tourism”

As reported in several major European publications, new laws have customs officials in France starting to crackdown on what they are calling “counterfeit tourism” – that is people from other countries who buy or bring in counterfeit goods while they are visiting France.

This is a significant shift in the enforcement of anti-counterfeiting laws. While other country’s police and customs authorities only target suppliers of counterfeit goods, in France, the authorities are now focusing on those who buy fake goods or bring counterfeit products into the country.

These new laws mean that French tourists could now be fined up to a maximum of €300,000 ($450,000) or face up to three years in jail if they are found to be in possession of or purchasing fake goods.

While certainly outside a traditional law enforcement tactic, this is seen as a significant step in changing the perception of the purchase of counterfeit goods with consumers. As with some crimes, many feel that the issue of fake goods is a “victimless” crime and do not understand the macro consequences of safety, health and economic well being that are impacted heavily by counterfeit goods.

It will be interesting to observe the enforcement, repercussions and effectiveness of these new laws in France.

Tuesday, August 4, 2009

Dramatic Rise in Drug Seizures by EU Customs

SecuringPharma.com posted a story by Phil Taylor on July 24th, outlining and giving background on an astounding increase in drug seizures by EU Customs Officials.

Some interesting tidbits include:

  • Seizures of pharmaceutical products at the European Union’s borders rose 57 per cent last year, while the total number of items detained more than doubled to around 8m items.

  • That increase came against a backdrop of a 13 per cent hike across all product categories to nearly 50,000 seizures overall, with the number of detained articles swelling to 180m from 80m in 2007.The report notes that seizures of medicines were among the most controversial developments in 2008.

  • There were cases in which generic medicines destined for a developing nation being seized in transit at EU borders, even though they did not infringe intellectual property rights in their destination markets (such as Latin America and Africa).

  • Around 70 per cent of all seizures were carried out at the request of an intellectual property rights holder, with the remainder ex officio actions by customs officials where there was a suspicion of infringement.

To read the story visit SecuringPharma.com at the following link: http://www.securingpharma.com/40/articles/184.php

Friday, July 24, 2009

The World Health Organization estimates Poland spends up to $31.6M USD Annually on Fake Medicine

The following report from Polish Radio estimates the annual spend by Polish consumers on counterfeit products and seizures by customs officials:

Customs officials say that medications are the third most often falsified product, giving the example of the popular sexual enhancement drug Viagra as often being made of Plaster of Paris.

WHO adds that it is particularly easy to purchase false drugs in Poland as one can acquire medication through the internet – on auction sites and on sites who claim to be pharmacies.

According to WHO, Poles spend around 100 million zloty (over $31.6 Million USD) a year on fake medicine – most often on sexual performance, weight loss and psychotropic drugs.

Cases have been regularly reported in the press, however, of Poles being taken for a ride by unscrupulous dealers. Recently a teenager from Silesia took Chinese booster drugs that turned out to contain significant quantities of lead. A resident of Elk, northern Poland, was arrested three weeks ago for selling false sexual enhancement drugs over the internet – made of plaster.

In 2008, Polish customs officials seized over 100,000 false drugs. Medications are the third most often falsified products following cigarettes and electronic devices.

To view article visit: polskieradio.pl

Monday, March 16, 2009

ICE, CBP, IPR Center Recognized for Outstanding Work in Trademark Protection

$272.7 million in counterfeits seized in 2008

Yesterday, Proctor and Gamble presented awards to United States Immigration and Customs Enforcement (ICE), U.S. Customs and Border Protection (CBP), and the National Intellectual Property Rights Coordination Center (IPR Center) for the successful partnership to further protect the company's trademark.

Companies are teaming with ICE and CBP in a united front against rampant counterfeiting. These agencies seized a variety of counterfeit goods with a market value of $272.7 million in 2008. This was an increase in seizures of 38 percent over seizures in 2007.

The National Intellectual Property Rights Coordination Center is the largest investigative arm of Department of Homeland Security, U.S. Immigration and Customs Enforcement (ICE) and targets those who manufacture, smuggle and distribute counterfeit and substandard products that put our citizens at risk.

We applaud those involved in this taskforce which include agents and analysts from ICE, U.S. Customs and Border Protection, and the FBI, who coordinate the U.S. government’s domestic and international law enforcement attack on IPR violations.

To learn more about IPR Center visit the ICE website at http://www.ice.gov.

Thursday, February 19, 2009

WHAT SHOULD PFIZER DO?

20 Pfizer products are counterfeited worldwide with Lipitor, Norvasco and Viagra topping the list.

The following is a news report that appeared in the Khaleej Times Online, regarding UAE’s efforts to combat faux pharmaceuticals and was authored by Sajila Saseendran and Emily Meredith (sajila@khaleejtimes.com) 15 February 2009.

The plain white boxes with dull grey lettering that line pharmacy shelves are supposed to contain medicine to improve people’s well being. But worldwide concern over the legitimacy of pharmaceuticals has increased markedly in the last three years. At an open forum attended by representatives of the Ministry of Health and private sector on Thursday in Sharjah, a representative pharmaceutical company Pfizer, said there is still a threat in the Middle East despite recent initiatives to curb illicit trade in fake – and potentially harmful – medicines.

“There are lots of initiatives (being taken) against counterfeiting here. But we cannot say that Middle East region is free of fake medicines, especially because of the presence of many free trade zones here,” Steve Allen, Europe and MENA Senior Director of Global Security for Pfizer, said. “Just a year ago, we had found counterfeited Lipitor in the retail chain here.” The World Health Organisation’s International Medical Products Anti-Counterfeiting Taskforce (IMPACT) estimates that fake pharmaceuticals – medicines produced by unlicensed manufacturers and introduced directly into the global supply chain –make up one per cent of drug sales in developed countries and approximately 30 per cent in some countries in Asia, Africa and Latin America. A British investigation in January into how the anti-psychotic drug, Zyprexa, entered the national health system highlighted the problem. Some reports suggested that drugs may have found their way into the United Kingdom in shipments that originated in China and passed through UAE ports.

The UAE’s Role: Dubai sits at the nexus of several transit points. Goods from Africa and Asia bound for the rest of the world pass through the city’s ports at a fast pace. This pace – approximately six hours for sea cargo to be checked, driven through Dubai’s roads and put on an outbound plane – appeals to people trying to ship illicit goods, according to Mohammad Al Mari, head of the Intellectual Property Rights Section of Dubai Customs.

“It’s not the location, it’s the infrastructure we have developed,” he said. Al Mari said he liked the pace, especially just a few years ago when the sea to air transfer time was one-third of today’s.” “It used to be fun, but not anymore with the traffic,” Al Mari said, smiling. But the speed is also the reason for his concerns. It has “given people the impression of using an easier, proper supply chain.”

Health and Customs officials in the UAE say they are working to counteract this impression with a set of new initiatives that include a national committee on counterfeit drugs established in January, portable devices for use at entry points to detect drugs and a proposal to increase the number of drug inspectors. The chair of the new national committee and the CEO of Medical Practice and Licence at the Ministry of Health, Dr. Amin Al Amiri, said the committee will extend its reach beyond the pharmaceuticals used to treat chronic conditions like diabetes, hypertension and cardiovascular diseases preferred by counterfeiters to medical devices and food supplements. “It is not just the fake medicines that pose a threat to public health. We need to prevent fake medical devices and food supplements, too,” Al Amiri said. “That is why the committee wants to monitor the import and export of medical devices and food supplements as well.”

The Ministry of Health requires all companies importing prescription, non-prescription and veterinary medicines to obtain a permit and send a copy to the Customs officials. Companies using the UAE’s ports to move these products also have to register. Al Amiri said the Ministry of Health (MoH) last month mandated pre-registration for food supplements and medical devices. “We have stringent procedures for registrations. Manufacturing companies have to produce a lot of certificates,” he said. Customs officials do not typically release medical shipments from port entry points until a trained pharmacist from MoH checks the shipment.

Al Mari said 70-80 per cent of the drugs entering Dubai’s ports are sampled and sent for testing at MoH’s drug control lab in Abu Dhabi. To ensure that the other cargo does not contain illicit imports, Al Mari said Dubai Customs fully offloads and inspects five to seven per cent of all cargo passing through the emirate. Twelve per cent of shipments are scanned. At certain spots, there are tougher regulations. At the dhow site for sea cargo, 100 per cent of all vessels are inspected. Al Amiri said companies have been given a grace period of six months to register their products. From June, shipments with unregistered drugs, devices and supplements will not be allowed entry in the UAE. “As of now, we are releasing the shipment, but we will not allow it go to the market unless the company registers the products within six months. It is for the protection of the community and to have best quality products in the country. We don’t want anything to enter the country unless it is registered and regulated.” The threat at home: Al Amiri said it was difficult to quantify the threat posed by counterfeit pharmaceuticals. “We don’t have a figure for the UAE. But we presume the threat of counterfeiting of mainly the drugs for chronic diseases, such as diabetes and hypertension, because of their wide use, and some other expensive pills,” he said. “We have never detected anything that is very dangerous or lethal. So far, a few of the drugs related to hypertension have been confiscated.” In 2008, Dubai Customs found only one instance of fake product: counterfeit hand cream. Recently, the UAE changed several policies in an effort to protect local residents. If inspectors suspect any item to be fake, it will be immediately reported to the police and sent to the drug inspection section for investigation. Non-registered drugs, once confiscated here, have to be sent back to the country of origin. “We have introduced this new system,” Al Amiri said. “We don’t allow any unwanted drugs to be destroyed here in our land. We don’t want any adverse impact to our environment and public health due to this.”

The UAE has also banned drug repackaging, once done on Emirati soil. “Some companies used to bring some of the non-registered drugs, repack it here and export it to some other countries. When they confiscate these, they think that all those drugs went from here which resulted in negative reputation to the UAE. We have stopped that practice and strictly banned the repackaging of medicines.”

Steve Allen from Pfizer said drug counterfeiting should be punishable more severely than in IPR violations because of the damages they cause. “It is not just about piracy like in the case of counterfeit CDs. Fake medicines can kill people and their trade is an organised crime,” Allen pointed out.

Private investigators employed by big pharmaceutical companies like Pfizer alert regulatory bodies about the entry of fake medicines into the market and any breach in the supply chain. “We would like the Customs to have the same level of focus on counterfeit medicines as on narcotics. Narcotic drug addicts know what they are taking and its potential dangers,” he said. “But it’s innocent patients whose health is affected because of counterfeit prescription drugs. Some can be lethal. We have found rat poison, boric acid and inkjet cartridges in some fake drugs.” About 20 Pfizer products are counterfeited worldwide with Lipitor, Norvasco and Viagra topping the list. Allen said counterfeiters were shifting focus to life-saving from lifestyle medicines because of expected delays in response. Anwar Hussain, assistant manager for purchases and R &D with the Medshop pharmacy chain, presented a paper on health hazards of fake drugs at Thursday’s forum. He called on pharmacists to buy medicines from authorised agents. “Pharmacists should ensure that all products are supplied against valid invoices stating the batch numbers. They should watch out for the products offered at high bonuses or extra discounts by unauthorised suppliers, monitor warnings from manufacturers and look out for pricing labels approved by the MoH.”